Genetic Testing for Maple Syrup Urine Disease (MSUD)

Most babies born with classic maple syrup urine disease (MSUD) are caught by routine newborn screening, but the window to act is short: without a diagnosis, the condition can become life threatening within the first two weeks of life.¹ Three different genes can cause MSUD, and carriers themselves typically have no symptoms at all. Maple Syrup Urine Disease genetic testing looks for changes in those genes ahead of time, so a diagnosis after birth is never your family's first warning, giving you the chance to take steps to avoid or manage the condition in your children.

What Is Maple Syrup Urine Disease?

MSUD gets its name from a distinctive sweet smell, often compared to maple syrup or burnt sugar, that can show up in a baby's urine, sweat, or earwax.¹ This occurs because the body can't properly break down three amino acids called leucine, isoleucine, and valine, which then build up to toxic levels. The classic form is the most severe and presents in the first days of life with poor feeding, vomiting, and lethargy that can progress quickly. Milder forms, sometimes called intermediate or intermittent MSUD, may not show up until later in childhood.

MSUD is caused by changes in one of three genes, and which gene is involved determines the type: BCKDHA causes type 1a, BCKDHB causes type 1b, and DBT causes type 2.² All three genes work together as part of the same enzyme system, so a change in any one of them can lead to MSUD.

Why Maple Syrup Urine Disease Testing Matters

Carrier testing is an essential step in proactive family planning. It helps you understand your risk before conceiving, and it can also inform care if your child is later diagnosed with MSUD.

Lifelong management

A strict, lifelong low protein diet is the main treatment for MSUD. In the most severe cases, a liver transplant is sometimes recommended, since it can help prevent additional metabolic crises and preserve neurological function.³ Even with careful management, the risk of a sudden metabolic crisis, triggered by illness, stress, or missed meals, never fully goes away.³ Some couples who learn their children are at risk of MSUD choose to take steps in their reproductive process to avoid passing on the condition, such as IVF with PGT-M or the use of donor gametes.

Limits of newborn screening

Newborn screening catches most cases quickly, but it isn't foolproof. A blood sample taken in the first 24 hours of life can come back as a false negative in a baby with classic MSUD, simply because the telltale amino acids haven't built up yet.⁴ Knowing your carrier status ahead of time means your care team can watch closely, regardless of what an early screen shows.

Understanding inheritance

MSUD is inherited in an autosomal recessive pattern. Carriers have one working copy of the gene and one nonworking copy, and are typically unaffected, since the one working copy is enough to prevent symptoms.² If both parents are carriers of a mutation in the same gene, each pregnancy carries a 25% chance the child inherits two nonworking copies, one from each parent, and is affected by MSUD. There's also a 50% chance the child is an unaffected carrier like the parents, and a 25% chance the child inherits two working copies of the gene.

How Likely Are You to Be a Carrier of MSUD?

1 in 97 individuals of Ashkenazi Jewish descent carry a change in BCKDHB, the gene associated with MSUD type 1b, making it one of the more common conditions on the Jewish genetic disease panel.²

MSUD carrier frequency isn't limited to one ancestry. Old Order Mennonite communities carry a distinct founder change in BCKDHA, with disease rates as high as 1 in 380 births, dramatically higher than the roughly 1 in 26,000 seen among Ashkenazi Jews or the far lower rates in the general population.⁵ Because the specific gene changes differ by ethnicity, a family's actual carrier risk depends heavily on ancestry.

Reasons to Get Carrier Testing for MSUD

Carrier screening is recommended for anyone planning a pregnancy, regardless of family history. That said, here are a few signs that may make expanded carrier screening especially worth considering:

1.

You Have Ashkenazi Jewish or Mennonite Ancestry

Both communities carry specific founder changes linked to MSUD at rates far above the general population, which makes ancestry alone a reasonable trigger for testing.

2.

You're Trying to Conceive

Since newborn screening isn't a guaranteed early catch, knowing your carrier status before pregnancy gives you a head start that a screen taken right after birth can't always provide.⁴ Testing before pregnancy also allows for the widest range of reproductive options to reduce the risk of passing on the condition.

3.

MSUD Runs in Your Family

If a relative has been diagnosed with MSUD, your own chance of carrying a change in the same gene is higher than average, and testing can clarify exactly what that risk looks like.

4.

Your Partner's Results Came Back Positive

If your partner already knows they carry a change in one of the MSUD genes, testing tells you whether your child could be at risk.

5.

You're Building Your Family With a Donor

Donor gametes carry the same genetic considerations as a partner would, so testing applies here, too.⁶

From Sample to Results

No clinic visit required. jscreen was built for accessibility, privacy, and ease, so nothing stands between you and the knowledge you need.
a mailing envelope being received with a genetic screening kit inside

Order Your Kit

Register online and receive a saliva collection kit shipped directly to your home within a few days.

a mailing envelope being received with a genetic screening kit inside

Collect Your Sample

Provide a simple saliva sample at home, following the easy step-by-step instructions included in your kit.

a mailing envelope being received with a genetic screening kit inside

Lab Analysis

Your sample is analyzed at a CLIA-accredited laboratory using advanced sequencing technology across the full gene panel.

a mailing envelope being received with a genetic screening kit inside

Receive Results

 Receive your results within 3 to 4 weeks. You can choose to schedule a complimentary consultation with a certified genetic counselor to review your findings.

Costs and Insurance Coverage

jscreen is committed to making carrier screening financially accessible, regardless of your insurance status.

Insurance Billing

Most commercial insurance plans cover carrier testing for individuals and couples planning to start or expand their family. Insurance plans also often cover carrier testing for individuals with Ashkenazi Jewish heritage. Your final cost depends on your family history and specific insurance plan. Our care navigators are here to help you work through the process and connect you with our financial assistance programs as needed.

Self-Pay Option

Prefer not to use insurance? jscreen offers a straightforward, competitive self-pay rate of $249, plus the upfront fee of $49, for a total of $298. This covers lab testing fees, physician review and test ordering, and access to our genetic counselors and care navigators throughout the testing process.

What Your Results Mean

Every screen from jscreen is reviewed by board-certified genetic counselors. Maple syrup urine disease test results generally appear as follows:

Positive (Carrier)

What This Means:
A positive result means you carry one working copy and one nonworking copy of one of the MSUD genes. You are not affected by MSUD and are not expected to ever develop symptoms, but you can pass the nonworking copy to a child. If you're planning a pregnancy, it's important that your partner be screened as well, since your child's risk depends on whether your partner carries a change in the same gene as you do.

Negative

What This Means:
A negative result means you have a significantly lower chance of being a carrier for MSUD. It does not eliminate your risk entirely, since no screen can detect every possible gene change. This matters especially here: because BCKDHA, BCKDHB, and DBT each carry their own distinct founder changes depending on ancestry, a panel that's thorough for one population's typical variant may still miss a rarer change specific to a different ethnic background.² It's important to choose a broad panel.

If You and Your Partner Are Both Carriers

What This Means:
If both partners carry a change in the same MSUD gene, each pregnancy has a 25% chance of being affected. Reproductive options are available to minimize this risk before a pregnancy is conceived. If you're already pregnant, maple syrup urine disease prenatal testing, through chorionic villus sampling or amniocentesis, can directly check whether a current pregnancy is affected, giving your care team time to prepare for treatment starting at birth rather than waiting for a newborn screen result.¹ Genetic counseling is strongly recommended at this stage.

Start Protecting Your Family'sFuture

MSUD can progress quickly once symptoms start, and the risk of a metabolic crisis never fully disappears, even with lifelong careful management.³ Knowing your carrier status ahead of time means less is left to chance for your children.

Frequently Asked Questions

What Does a Maple Syrup Urine Disease Genetic Test Look For?

A maple syrup urine disease genetic test looks for disease-causing mutations in the three genes known to cause MSUD. Because different ancestries carry different founder changes, most panels are built to include the specific variants most common in Ashkenazi Jewish and Mennonite populations, while also scanning the entirety of all three genes for changes that shut down their function.²,⁵

Is There a Maple Syrup Urine Disease Screening Test Done After Birth, Too?

Yes, and it's different from carrier testing. Newborn screening checks a baby's blood directly for biochemical signs of MSUD shortly after birth, while carrier testing checks a parent's genes beforehand to estimate the chance of having an affected child in the first place.

Are There Prenatal Tests Available for Maple Syrup Urine Disease?

Yes. If both partners are found to be carriers, maple syrup urine disease prenatal testing, such as chorionic villus sampling or amniocentesis, can diagnose whether a current pregnancy is affected, rather than waiting until birth.¹

What Do Maple Syrup Urine Disease Test Results Mean?

A negative result means you're very unlikely to carry a mutation in any of the three MSUD genes, though it can't rule out every possible change. A positive result means you carry one working and one nonworking copy of one of the genes, with no health effects to you personally.⁷

Do I Need Genetic Counseling After Genetic Testing for Maple Syrup Urine Disease?

It isn't required, but it's strongly recommended, especially if your result is positive. Every screen through jscreen includes access to a complimentary consultation with a board-certified genetic counselor, who can explain what your specific results mean and what your options are going forward.

What Happens if My Partner and I Are Both Carriers?

Each pregnancy would have a 25% chance of being affected by MSUD. At that point, most people work with a genetic counselor to talk through their options, which can include prenatal diagnostic testing during a current pregnancy, or other family planning approaches if you haven't conceived yet.¹

Still Have Questions?

We’d love to hear from you! Check our FAQ page, or contact us.

References

  1. Maple Syrup Urine Disease. Cleveland Clinic. Published July 29, 2025. Accessed August 4, 2026.
    https://my.clevelandclinic.org/health/diseases/21168-maple-syrup-urine-disease
  2. Maple Syrup Urine Disease Types Ia, Ib, and II. Norton and Elaine Sarnoff Center for Jewish Genetics. Published November 7, 2023. Accessed August 4, 2026.
    https://www.jewishgenetics.org/genetic-disorders/search-genetic-disorders/maple-syrup-urine-disease-types-ia-iib-and-ii/
  3. Maple Syrup Urine Disease. National Organization for Rare Disorders. Published October 30, 2024. Accessed August 4, 2026.
    https://rarediseases.org/rare-diseases/maple-syrup-urine-disease/
  4. Maple Syrup Urine Disease (MSUD). Newborn Screening Program. New York State Department of Health, Wadsworth Center. Accessed August 4, 2026.
    https://www.wadsworth.org/public-health-programs/newborn-screening/newborn-screening-program/maple-syrup-urine-disease-msud
  5. Stone WL, Basit H, Los E. Maple Syrup Urine Disease. In: StatPearls. StatPearls Publishing. Updated March 3, 2024. Accessed August 4, 2026.
    https://www.ncbi.nlm.nih.gov/books/NBK557773/
  6. Carrier Screening for Family Planning. Mayo Clinic Health System. Published June 23, 2023. Accessed August 4, 2026.
    https://www.mayoclinichealthsystem.org/hometown-health/speaking-of-health/carrier-screening-for-family-planning
  7. Variant of Uncertain Significance (VUS). Genetics Glossary. National Human Genome Research Institute. Genome.gov. Accessed August 4, 2026.
    https://www.genome.gov/genetics-glossary/Variant-of-Uncertain-Significance-VUS
  8. Variants of Uncertain Significance, How to Think About Them. Personalized Integrative Care. Published November 19, 2025. Accessed August 4, 2026.
    https://www.surrogacy4all.com/variants-of-uncertain-significance-how-to-think-about-them/